U.S. Charges 15 in California Healthcare Fraud Cases Involving Nearly $2 Billion
By Beenish Rashid — SCN NEWS
LOS ANGELES— U.S. federal prosecutors announced criminal charges against 15 people in Southern California on Thursday in healthcare fraud cases involving nearly $2 billion in allegedly fraudulent claims, targeting suspected schemes involving addiction treatment centers, unnecessary medical procedures and hospice services.
The Justice Department said eight defendants were arrested during the operation, which involved federal law enforcement agencies and prosecutors in the Los Angeles area. Six of those charged were medical professionals, according to officials, who described the cases as part of a broader effort to investigate fraud affecting government healthcare programs and private insurers.
The allegations include more than $1.6 billion in billing connected to purported substance abuse treatment programs, approximately $134 million in claims involving invasive arterial procedures and more than $138 million associated with hospice services. The amounts represent alleged fraudulent claims identified by prosecutors, not money established by a court to have been stolen or recovered.
The charges were announced by the U.S. Attorney's Office for the Central District of California and the Justice Department's National Fraud Enforcement Division. Federal officials said the investigations involved the FBI, the Department of Health and Human Services Office of Inspector General and other law enforcement agencies.
A central case involves an alleged network of addiction treatment businesses that prosecutors say recruited vulnerable individuals from across the United States and transported them to Southern California and other locations. The government alleges that operators submitted insurance claims for treatment that was unnecessary, inadequately provided or never delivered.
According to the indictment described by the Justice Department, some prospective patients were offered travel, accommodation, money and other incentives to enter the programs. Prosecutors allege that individuals were then moved among treatment facilities to generate additional insurance claims, regardless of whether the services were medically appropriate.
The government also alleges that some patients were housed in overcrowded or unsanitary conditions and faced restrictions on leaving facilities. Those accusations raise questions extending beyond financial losses to the safety and treatment of people seeking help for substance use disorders.
Four defendants identified in the principal addiction treatment case are Nathan Young, David Young, Honey Phipps and Cody Phipps. Prosecutors allege that the operation involved dozens of purported treatment businesses and more than $1.6 billion in insurance billing.
A separate defendant, Nicholas Moore, has pleaded guilty in a related substance abuse treatment fraud case, according to the Justice Department. His case forms part of the wider prosecution effort, although his legal status differs from that of defendants whose charges remain contested.
Another major case concerns alleged unnecessary cardiovascular procedures performed on Medicare patients. Federal prosecutors charged cardiothoracic surgeon Harold Tabaie, 78, of Anaheim, and chiropractor Hany Malek, 61, of Tarzana, in connection with a scheme involving approximately $135 million in Medicare billing.
The indictment alleges that Malek presented himself as a medical doctor and referred patients for atherectomies, procedures intended to remove plaque from arteries. Prosecutors say Tabaie performed procedures on some patients who did not have the medical conditions used to justify the treatment.
Federal authorities further allege that repeat procedures were performed in certain cases and that some patients experienced pain and discomfort. Investigators said unusual Medicare billing patterns helped identify the case for further examination.
Both men face healthcare fraud charges, while Malek also faces bank fraud counts involving allegations about Paycheck Protection Program loan applications. These accusations remain subject to the judicial process, and the filing of an indictment does not establish guilt.
The Justice Department also identified alleged hospice billing schemes involving more than $138 million in claims. Prosecutors say the cases involved billing for hospice services associated with patients who were not terminally ill, a central eligibility requirement for such care.
In addition, officials described a separate $270 million Medi-Cal pharmacy fraud allegation involving prescriptions that prosecutors say were not legitimate. The government identified that matter as a distinct case, and its claimed amount should not automatically be added to the approximately $2 billion headline figure without accounting for how the cases were grouped.
The California operation comes as the Trump administration expands federal investigations into suspected fraud involving publicly funded assistance programs. The Justice Department has placed increased emphasis on healthcare and benefit-payment schemes, including those affecting Medicare, Medicaid and food assistance.
On Wednesday, federal authorities announced a separate nationwide enforcement effort targeting alleged fraud involving the Supplemental Nutrition Assistance Program, commonly known as SNAP. The Justice Department said that operation involved more than 40 defendants and nearly $42 million in suspected SNAP-related losses.
The administration has also promoted financial incentives for reporting suspected misuse of federal funds. President Donald Trump and Vice President JD Vance announced a $25 million whistleblower initiative earlier this week as part of the government's broader anti-fraud agenda.
Although the California healthcare cases and the national SNAP initiative fall within the same enforcement priority, they concern different programs, defendants and alleged conduct. Their financial figures should therefore be reported separately rather than presented as a single fraud scheme.
The California prosecutions also highlight the distinction between fraudulent claims submitted to insurers and actual financial losses. A billing amount can include claims that were rejected, unpaid or otherwise disputed, meaning it does not necessarily reflect the amount disbursed by public programs or private insurers.
That distinction is particularly important in large healthcare fraud investigations, where prosecutors may describe the value of allegedly false claims across multiple businesses and several years. Courts must assess the evidence presented in each case before criminal responsibility and any resulting financial penalties can be determined.
The Justice Department said the latest cases were investigated through a combination of financial analysis, healthcare billing records and traditional law enforcement methods. Officials emphasized that suspicious patterns in medical claims can help identify possible misconduct, particularly when providers submit unusually high volumes of procedures or services.
The cases are also expected to draw attention to oversight of addiction treatment providers and hospice operators, sectors that serve patients who may be especially vulnerable to exploitation. Regulators face the challenge of detecting improper billing without disrupting access to legitimate care.
Federal officials have described the California operation as a significant enforcement action, but the ultimate outcome will depend on court proceedings, evidence presented by prosecutors and responses from the defendants.
All defendants who have not entered guilty pleas are presumed innocent unless and until proven guilty beyond a reasonable doubt. The Justice Department's allegations, including the amounts associated with the suspected schemes, remain subject to legal examination.
The charges mark a new stage in federal efforts to scrutinize healthcare spending in California, with prosecutors seeking to determine whether treatment businesses and medical professionals improperly billed insurers while placing patients at risk.